Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Two-thirds of the UK population are either overweight or obese – a crisis that costs billions each year in healthcare and ...

The RESPOND trial adapted to COVID-19 disruptions by shifting to a cluster-parallel randomized design, enabling analysis ...

This study uncovers the hepatic vagal nerve's influence on circadian food intake, presenting new avenues for obesity treatment through targeted interventions.

We have had someone in the hospital over a year. Some patients have a really poor experience,' doctor admits as Welsh ...